| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/22/2011 | EP2336330A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 06/22/2011 | EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336313A1 Methods for production of proteins |
| 06/22/2011 | EP2336192A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 06/22/2011 | EP2336189A1 Prostate cancer diagnosis and treatment |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336178A1 Methods and compositions for inhibiting C-Met dimerization and activation |
| 06/22/2011 | EP2336176A1 Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes |
| 06/22/2011 | EP2336175A1 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 06/22/2011 | EP2336171A1 Novel targets for the treatment of proliferative diseases |
| 06/22/2011 | EP2336170A2 Recombinant triplex scaffold-based polypeptides |
| 06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336166A1 Compositions that inhibit proliferation of cancer cells |
| 06/22/2011 | EP2336165A1 Peptides and compounds that bind to the thrombopoietin receptor |
| 06/22/2011 | EP2336164A1 Recombinant production of heparin binding proteins |
| 06/22/2011 | EP2336163A1 Sclerostin binding agents |
| 06/22/2011 | EP2336162A1 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 06/22/2011 | EP2336161A2 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof. |
| 06/22/2011 | EP2336160A2 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof. |
| 06/22/2011 | EP2336159A2 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof. |
| 06/22/2011 | EP2336158A1 Dry analytical element for measurement of canine CRP |
| 06/22/2011 | EP2336157A2 Gene products which are differentially expressed in tumours and use thereof |
| 06/22/2011 | EP2336156A2 Gene products which are differentially expressed in tumours and use thereof |
| 06/22/2011 | EP2336155A1 Antimicrobial peptides |
| 06/22/2011 | EP2336154A2 Agent that modulates physiological condition of pests, involved in insect vesicle-fusing atpase activity |
| 06/22/2011 | EP2336153A1 Improved expression systems with SEC-system secretion |
| 06/22/2011 | EP2336152A1 Thermostable xylanase for the selective hydrolysis of pentose-containing polysaccharides |
| 06/22/2011 | EP2336151A1 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336150A2 Replikin peptides and uses thereof |
| 06/22/2011 | EP2335739A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof |
| 06/22/2011 | EP2335724A1 Immunisation against chlamydia trachomatis |
| 06/22/2011 | EP2335723A1 Immunisation against chlamydia trachomatis |
| 06/22/2011 | EP2335722A2 Use of gelsolin to treat infections |
| 06/22/2011 | EP2335718A1 Non-cytotoxic protein conjugates |
| 06/22/2011 | EP2335716A2 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 06/22/2011 | EP2335715A2 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 06/22/2011 | EP2334798A2 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture |
| 06/22/2011 | EP2334786A2 Isolation and identification of glycosaminoglycans |
| 06/22/2011 | EP2334699A1 Purification of erythropoietin |
| 06/22/2011 | EP2334698A1 Marker peptides for determining the occurrence of an inflammatory state in a subject |
| 06/22/2011 | EP2334697A1 Peptidomimetic macrocycles |
| 06/22/2011 | EP2334696A1 G6pc2-encoded beta cell surface tags |
| 06/22/2011 | EP2334695A1 Therapeutic ribonucleases |
| 06/22/2011 | EP2334694A1 Viral polypeptides and methods |
| 06/22/2011 | EP2334693A1 Methods of long-term culture of eukaryotic cells and uses thereof |
| 06/22/2011 | EP2334338A2 Polymer conjugates of c-peptides |
| 06/22/2011 | EP2334336A1 Polymer conjugates of osteocalcin peptides |
| 06/22/2011 | EP2334335A1 Polymer conjugates of cd-np peptides |
| 06/22/2011 | EP2334333A1 Polymer conjugates of v681-like peptides |
| 06/22/2011 | EP2334329A1 Immunoenhancer-linked oligomeric hiv vaccines |
| 06/22/2011 | EP2334324A2 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/22/2011 | EP2334320A2 Biopolymer conjugates comprising an interleukin-11 analog |
| 06/22/2011 | EP2334318A2 Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding |
| 06/22/2011 | EP2334316A1 Process for the synthesis of (aib8,35)hglp-1(7-36)-nh2 |
| 06/22/2011 | EP2097444B1 Method using a transgenic animal with enhanced immune response |
| 06/22/2011 | EP1987062B1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| 06/22/2011 | EP1917363B1 Method for making mature insulin polypeptides |
| 06/22/2011 | EP1888624B1 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 06/22/2011 | EP1831381B1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 06/22/2011 | EP1791861B1 Protein regulating leaf longevity of plants, the gene thereof and their use |
| 06/22/2011 | EP1724342B1 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli |
| 06/22/2011 | EP1680507B1 Bacterial expression of protease inhibitors and variants thereof |
| 06/22/2011 | EP1680503B1 Recombinant production of antimicrobial agents |
| 06/22/2011 | EP1629006B1 Phl p 5a derivatives with reduced allergenicity and retained t-cell reactivity |
| 06/22/2011 | EP1619951B1 Methods and compositions for treating disorders |
| 06/22/2011 | EP1595949B1 Method of degrading plastic and process for producing useful substance using the same |
| 06/22/2011 | EP1328545B1 Human gene critical to fertility |
| 06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 06/22/2011 | EP1109827B1 Bioactive peptides |
| 06/22/2011 | DE102009055015A1 Hefe-Sekretionssystem auf Basis einer Signalsequenz aus der Hydrophobin 1-Gensequenz von Trichoderma reesei Yeast secretion system on the basis of a signal sequence of the hydrophobin 1 gene sequence of Trichoderma reesei |
| 06/22/2011 | CN1891714B Ligand for herpes simplex virus entry mediator and methods of use |
| 06/22/2011 | CN1890381B Method of diagnosing breast cancer |
| 06/22/2011 | CN1820024B Novel poly(ethylene glycol) modified compounds and uses thereof |
| 06/22/2011 | CN1816622B Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein |
| 06/22/2011 | CN1786018B Separation and purification of high purity hemoglobin and virus inactivation technology |
| 06/22/2011 | CN1739029B Prion protein ligands and methods of use |
| 06/22/2011 | CN1560078B Tumor antigen based on products of the tumor suppressor gene WT1 |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN1244896B Non-M, non-O, HIV-1 strains, fragments and applications |
| 06/22/2011 | CN102105588A Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 06/22/2011 | CN102105491A Interleukin-21 receptor binding proteins |
| 06/22/2011 | CN102105490A Fucose a1-6-specific lectin |
| 06/22/2011 | CN102105489A Expression and assembly of human group C rotavirus-like particles and uses thereof |
| 06/22/2011 | CN102105488A Methods of long-term culture of eukaryotic cells and uses thereof |
| 06/22/2011 | CN102105486A Peptidylarginine deiminase (PAD) inhibitors |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102105165A Compositions and methods of use of ORF 554 from beta hemolytic streptococcal strains |
| 06/22/2011 | CN102105163A Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof |
| 06/22/2011 | CN102105162A The use of Wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 06/22/2011 | CN102102106A Methods for modifying plant characteristics |
| 06/22/2011 | CN102101888A Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof |
| 06/22/2011 | CN102101886A Variable-conformation recombinant interferon crystal, and three-dimensional structure and use thereof |
| 06/22/2011 | CN102101885A Human interleukin-II mutant of low-inductivity suppressor T cells and use thereof |
| 06/22/2011 | CN102101884A Preparation method and use of donkey-hide gelatin polypeptide |
| 06/22/2011 | CN102101883A Method for preparing casein from low-temperature bean pulp serving as raw material |
| 06/22/2011 | CN102101882A Plant low temperature stress resistance-related protein and encoding gene and application thereof |
| 06/22/2011 | CN101538266B Rogridone hapten, artificial antigen and antibody as well as preparation method and application thereof |